A Study to Investigate the Relative Bioavailability of 2 Different Formulations of AZD4144, the Effect of Food and Omeprazole on the Pharmacokinetics of AZD4144 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 23, 2025

Primary Completion Date

June 27, 2025

Study Completion Date

June 27, 2025

Conditions
Healthy Participants
Interventions
DRUG

AZD4144

Participants will receive AZD4144 orally.

DRUG

Omeprazole

Participants will receive omeprazole orally.

Trial Locations (1)

HA1 3UJ

Research Site, Harrow

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Parexel

INDUSTRY

lead

AstraZeneca

INDUSTRY